Economic assessment of NGS testing workflow for NSCLC in a healthcare setting
Background: The molecular diagnostic and therapeutic pathway of Non-Small Cell Lung Cancer (NSCLC) stands as a successful example of precision medicine. The scarcity of material and the increasing number of biomarkers to be tested have prompted the routine application of next-generation-sequencing (...
Main Authors: | Davide Seminati, Vincenzo L'Imperio, Gabriele Casati, Joranda Ceku, Daniela Pilla, Carla Rossana Scalia, Gianluca Gragnano, Francesco Pepe, Pasquale Pisapia, Luca Sala, Diego Luigi Cortinovis, Francesca Bono, Umberto Malapelle, Giancarlo Troncone, Silvia Novello, Fabio Pagni |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Heliyon |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024053039 |
Similar Items
-
A Narrow NGS Panel in the Analysis of KRAS p.G12C Mutation in Longitudinal Series of NSCLC Patients: A Pilot Study
by: F. Pepe, et al.
Published: (2023-11-01) -
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions
by: Caterina De Luca, et al.
Published: (2023-10-01) -
BRAF: A Two-Faced Janus
by: Pasquale Pisapia, et al.
Published: (2020-11-01) -
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer
by: Pasquale Pisapia, et al.
Published: (2021-07-01) -
Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients.
by: Eirini Papadopoulou, et al.
Published: (2019-01-01)